聚合酵素链锁反应(PCR)的全球市场:现状分析与预测(2022年～2028年)

全球聚合酵素链锁反应(PCR)的市场规模，由于研究机关和法医学研究所的聚合酵素链锁反应(PCR)的利用增加，预计稳定成长约9％。

本报告提供全球聚合酵素链锁反应(PCR)市场相关调查分析，市场动态，趋势与机会，企业简介等资讯。

目录

第1章 市场简介

第2章 调查手法、前提条件

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对聚合酵素链锁反应(PCR)市场的影响

第6章 聚合酵素链锁反应(PCR)市场收益(2020年～2028年)

第7章 市场考察:各类型

• 即时RT-PCR
• 传统的PCR
• 数位PCR
• 其他

第8章 市场考察:各用途

• 感染疾病
• 癌症
• 遗传性疾病
• 其他

第9章 市场考察:各终端用户

• 医院、诊疗所
• 製药、生物科技产业
• 学术、研究所
• 其他

第10章 市场考察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他的北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他的欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他的亚太地区
• 其他地区

第11章 聚合酵素链锁反应(PCR)的市场动态

• 推动市场要素
• 市场课题
• 影响的分析

第12章 聚合酵素链锁反应(PCR)的市场机会

第13章 聚合酵素链锁反应(PCR)的市场趋势

第14章 需求端和供应端的分析

• 需求端分析
• 供应端分析

第15章 价值链分析

第16章 价格分析

第17章 策略性考察

第18章 竞争模式

• 竞争情形
  • 波特的五力分析

第19章 企业简介

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN
• Agilent Technologies Inc.
• Standard Biotools
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Abbott
• Promega Corporation
• Takara Bio Inc.

第20章 免责声明

Polymerase chain reaction (PCR) is a laboratory technique used to amplify DNA sequences. The polymerase chain reaction enables investigators to obtain the large quantities of DNA that are required for various experiments and procedures in molecular biology, forensic analysis, evolutionary biology, and medical diagnostics. The rise in demand for advanced diagnostics and growing application in clinical diagnostics is expected to increase the demand for polymerase reaction tests. For instance, in August 2022, GenScript USA launched a real-time polymerase chain reaction (RT-PCR) monkeypox test for research lab use. The kit is based on RT-PCR technology and PCR amplification in one-step.

The Polymerase Chain Reaction (PCR) Market is expected to grow at a steady rate of around 9% owing to the increasing application of polymerase chain reaction (PCR) in research and forensic laboratories. Major companies in the market growing focus on gene-based research and the launch of new and innovative technologies. For instance, in July 2021, PathStore, a France-based multinational company launched the COVID-19 RT-PCR test priced at ₹299 (USD 3.65), the lowest so far among the private sector diagnostic industry.

Based on type, the polymerase chain reaction market is segmented into real-time RT-PCR, conventional PCR, digital PCR, and others. The digital PCR segment is expected to grow with a significant CAGR during the forecast period. Digital PCR is widely used for molecular detection with accurate quantification. Moreover, advancements in digital PCR technology and rises in product launches propel the segment. For instance, in July 2021, Stilla Technologies launched an access program for the industry's first six-color digital PCR system. The new dPCR platform offers high multiplexing and sensitivity for advancing cancer & liquid biopsy studies, cell & gene therapies, infectious disease & COVID-19 research, and environmental testing.

Based on application, the polymerase chain reaction market is segmented into infectious diseases, cancer, inherited disorders, and others. The cancer segment held a significant market share in 2021. The rising prevalence of cancer is the significant factor responsible for the growth of the market as PCR techniques are used in various gene-based studies which provide physicians with more data about the causes of cancer and change the way some forms of the disease are treated. According to the American Cancer Society, in 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the U.S..

Based on end-users, the market is fragmented into hospitals & clinics, pharmaceutical & biotechnology industries, academic & research labs, and others. Among these, hospitals & clinics are expected to grow with a significant CAGR during the forecast period. This is mainly due to the rising incidences of various infectious and chronic diseases coupled with the rapid incorporation of PCR techniques in clinical diagnostics globally. Also, the clinical applications of PCR technologies are vast and offer opportunities to improve healthcare across the breadth of medical specialties.

For a better understanding of the market adoption of the Polymerase chain reaction (PCR) industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Europe is the second dominant region due to the increasing prevalence of cancer cases that require an accurate diagnosis. Furthermore, the increase in research and development activities for advancement in PCR technology and the rise in collaboration agreements among companies for development boosts the growth of the polymerase chain reaction market. For instance, in January 2022, Qiagen, a leading developer of diagnostic devices, entered into collaboration with Atila BioSystems and Actome GmbH to provide non-invasive prenatal testing (NIPT) solutions to QIAGEN's dPCR and licensing & co-marketing agreement.

Some of the major players operating in the market include: Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Polymerase Chain Reaction Market
• 2.2. Research Methodology of the Polymerase Chain Reaction Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE POLYMERASE CHAIN REACTION MARKET

6 POLYMERASE CHAIN REACTION MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TYPE

• 7.1. Real-Time RT-PCR
• 7.2. Conventional PCR
• 7.3. Digital PCR
• 7.4. Others

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Infectious Diseases
• 8.2. Cancer
• 8.3. Inherited Disorders
• 8.4. Others

9 MARKET INSIGHTS BY END USER

• 9.1. Hospitals & Clinics
• 9.2. Pharmaceutical & Biotechnology Industries
• 9.3. Academic & Research Labs
• 9.4. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. The U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. The U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 POLYMERASE CHAIN REACTION MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 POLYMERASE CHAIN REACTION MARKET OPPORTUNITIES

13 POLYMERASE CHAIN REACTION MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

• 18.1. Competitive Landscape
  • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

• 19.1. Thermo Fisher Scientific Inc.
• 19.2. Bio-Rad Laboratories Inc.
• 19.3. QIAGEN
• 19.4. Agilent Technologies Inc.
• 19.5. Standard Biotools
• 19.6. F. Hoffmann-La Roche Ltd.
• 19.7. Merck & Co. Inc.
• 19.8. Abbott
• 19.9. Promega Corporation
• 19.10. Takara Bio Inc.

20 DISCLAIMER